356572-22-0

Basic information

• Product Name: 1-(benzyloxycarbonyl)amino-3,5-dimethyl-7-(3-bromopropylcarbonyloxy)adamantine
• CAS NO: 356572-22-0
• Molecular Weight: 478.426
• Mol File: 356572-22-0.mol

Chemical Properties

• CAS DataBase Reference: 1-(benzyloxycarbonyl)amino-3,5-dimethyl-7-(3-bromopropylcarbonyloxy)adamantine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(benzyloxycarbonyl)amino-3,5-dimethyl-7-(3-bromopropylcarbonyloxy)adamantine(356572-22-0)
• EPA Substance Registry System: 1-(benzyloxycarbonyl)amino-3,5-dimethyl-7-(3-bromopropylcarbonyloxy)adamantine(356572-22-0)

Safety Data

• Hazardous Substances Data: 356572-22-0(Hazardous Substances Data)

Upstream product

• 356572-20-8 1-(benzyloxycarbonyl)amino-3,5-dimethyl-7-hydroxyadamantane 
• 927-58-2 4-bromobutyroyl chloride 
• 356572-08-2 1-hydroxy-3-amino-5,7-dimethyladamantane hydrochloride 
• 31139-36-3 dibenzyl dicarbonate 

Relevant articles and documents

Methods for treating neuropsychiatric disorders with nmda receptor antagonists

The present invention relates to compositions and methods for treating a human patient afflicted with a neuropsychiatric disorder. Specifically, the invention provides for compositions and methods of modulating or antagonizing the activity of neuronal NMD

Aminoadamantane derivatives as therapeutic agents

The present invention provides novel aminoadamantane derivatives, methods of making the derivatives, compositions including the novel aminoadamantane derivatives, and methods for the treatment and prevention of neurological diseases using the derivatives